Quantitative analyses of retinal vascular area and density after different methods to reduce VEGF in a rat model of retinopathy of prematurity.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Investigative Ophthalmology and Visual Science

• Publication date

  2014-02-04

• Fields of study

  Medicine

• Identifiers
  DOI 10.1167/iovs.13-13429PMID 24425858PMCID PMC3915769
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intravitreal low‐dosage bevacizumab for retinopathy of prematurity

  2014cited by this paper
• Hypoxic retinal Müller cells promote vascular permeability by HIF-1–dependent up-regulation of angiopoietin-like 4

  2013cited by this paper
• Screening Examination of Premature Infants for Retinopathy of Prematurity

  2013cited by this paper
• Short hairpin RNA-mediated knockdown of VEGFA in Müller cells reduces intravitreal neovascularization in a rat model of retinopathy of prematurity.

  2013cited by this paper
• Nutrition, insulin-like growth factor-1 and retinopathy of prematurity.

  2013cited by this paper
• Anti-VEGF antibody leads to later atypical intravitreous neovascularization and activation of angiogenic pathways in a rat model of retinopathy of prematurity.

  2013cited by this paper
• From oxygen to erythropoietin: relevance of hypoxia for retinal development, health and disease.

  2012cited by this paper
• Omega-3 polyunsaturated fatty acids preserve retinal function in type 2 diabetic mice

  2012cited by this paper
• Treatment of retinopathy of prematurity with vascular endothelial growth factor inhibitors.

  2012cited by this paper
• Mechanisms and management of retinopathy of prematurity.

  2012cited by this paper
• An evidence-based meta-analysis of vascular endothelial growth factor inhibition in pediatric retinal diseases: part 1. Retinopathy of prematurity.

  2012cited by this paper
• Reactivation of retinopathy of prematurity after bevacizumab injection.

  2012cited by this paper
• VEGF-mediated STAT3 activation inhibits retinal vascularization by down-regulating local erythropoietin expression.

  2012cited by this paper
• Ischemic neurons prevent vascular regeneration of neural tissue by secreting semaphorin 3A.

  2011cited by this paper
• Studies on the pathogenesis of avascular retina and neovascularization into the vitreous in peripheral severe retinopathy of prematurity (an american ophthalmological society thesis).

  2010cited by this paper
• Astrocyte hypoxic response is essential for pathological but not developmental angiogenesis of the retina

  2010cited by this paper
• Maintaining retinal astrocytes normalizes revascularization and prevents vascular pathology associated with oxygen‐induced retinopathy

  2010cited by this paper
• Increased angiogenic factors associated with peripheral avascular retina and intravitreous neovascularization: a model of retinopathy of prematurity.

  2010cited by this paper
• Activated NAD(P)H oxidase from supplemental oxygen induces neovascularization independent of VEGF in retinopathy of prematurity model.

  2008cited by this paper
• Neutralizing antibody to VEGF reduces intravitreous neovascularization and may not interfere with ongoing intraretinal vascularization in a rat model of retinopathy of prematurity

  2008cited by this paper
• Endogenous VEGF Is Required for Visual Function: Evidence for a Survival Role on Müller Cells and Photoreceptors

  2008cited by this paper
• Neutralizing VEGF decreases tortuosity and alters endothelial cell division orientation in arterioles and veins in a rat model of ROP: relevance to plus disease.

  2008cited by this paper
• Targeted transgene expression in muller glia of normal and diseased retinas using lentiviral vectors.

  2007cited by this paper
• Orientation of endothelial cell division is regulated by VEGF signaling during blood vessel formation.

  2007cited by this paper
• Inhibition of NAD(P)H oxidase reduces apoptosis and avascular retina in an animal model of retinopathy of prematurity

  2007cited by this paper
• Retinopathy of prematurity

  2007cited by this paper
• Oxygen-dependent diseases in the retina: role of hypoxia-inducible factors.

  2006cited by this paper
• Use of intravitreal bevacizumab as a preoperative adjunct for tractional retinal detachment repair in severe proliferative diabetic retinopathy.

  2006cited by this paper
• The extracellular adherence protein (Eap) of Staphylococcus aureus inhibits wound healing by interfering with host defense and repair mechanisms.

  2006cited by this paper
• Differential effects of n-3 polyunsaturated fatty acids on metabolic control and vascular reactivity in the type 2 diabetic ob/ob mouse.

  2006cited by this paper
• The Role of Maternal Factors, Postnatal Nutrition, Weight Gain, and Gender in Regulation of Serum IGF-I among Preterm Infants

  2005cited by this paper
• Selective suppression of pathologic, but not physiologic, retinal neovascularization by blocking the angiotensin II type 1 receptor.

  2005cited by this paper
• Inhibition of tumor necrosis factor-alpha improves physiological angiogenesis and reduces pathological neovascularization in ischemic retinopathy.

  2005cited by this paper
• Increased ocular levels of IGF-1 in transgenic mice lead to diabetes-like eye disease.

  2004cited by this paper
• Variable oxygen and retinal VEGF levels: correlation with incidence and severity of pathology in a rat model of oxygen-induced retinopathy.

  2004cited by this paper
• Inhibition of oxygen-induced retinopathy in RTP801-deficient mice.

  2004cited by this paper
• VEGF isoforms and their expression after a single episode of hypoxia or repeated fluctuations between hyperoxia and hypoxia: relevance to clinical ROP.

  2004cited by this paper
• Hypoxia-Inducible Factor-1 Mediates Activation of Cultured Vascular Endothelial Cells by Inducing Multiple Angiogenic Factors

  2003cited by this paper
• Identification of a Novel Hypoxia-Inducible Factor 1-Responsive Gene, RTP801, Involved in Apoptosis

  2002cited by this paper
• Regression of ocular neovascularization in response to increased expression of pigment epithelium-derived factor.

  2002cited by this paper
• Molecular mechanisms of transcription activation by HLF and HIF1α in response to hypoxia: their stabilization and redox signal‐induced interaction with CBP/p300

  1999cited by this paper
• A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development.

  1997cited by this paper
• Supplemental oxygen therapy. Basis for noninvasive treatment of retinopathy of prematurity.

  1995cited by this paper
• Exposure to Alternating Hypoxia and Hyperoxia Causes Severe Proliferative Retinopathy in the Newborn Rat

  1994cited by this paper
• Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

  1994cited by this paper
• Prolonged dexamethasone therapy reduces the incidence of cryotherapy for retinopathy of prematurity in infants of less than 1 kilogram birth weight with bronchopulmonary dysplasia.

  1992cited by this paper
• © 2011 Molecular Vision

  year unknowncited by this paper

• Pathophysiology of Retinopathy of Prematurity.

  2023cites this paper
• Comparison of Fluorescein Angiography Findings in Stage 3 Retinopathy of Prematurity in Zone II Treated With or Without Anti-VEGF

  2022influential citation
• Plasma Levels of Vascular Endothelial Growth Factor After Low-Dose Bevacizumab Treatment for Retinopathy of Prematurity Study-More Questions Than Answers?-Reply.

  2022cites this paper
• Interleukin-19 Promotes Retinal Neovascularization in a Mouse Model of Oxygen-Induced Retinopathy

  2022cites this paper
• Hematopoietic Cells Influence Vascular Development in the Retina

  2022cites this paper
• Effects and Mechanism of Action of PX-478 in Oxygen-Induced Retinopathy in Mice

  2020cites this paper
• Slow progressive perifoveal vascular formation in an infant with aggressive posterior retinopathy of prematurity.

  2020cites this paper
• Comparison of fluorescein angiographic findings in type 1 and type 2 retinopathy of prematurity with intravitreal bevacizumab monotherapy and spontaneous regression

  2019cites this paper
• Discovering Mechanisms in the Changing and Diverse Pathology of Retinopathy of Prematurity: The Weisenfeld Award Lecture

  2019cites this paper
• Enhancing Retinal Endothelial Glycolysis by Inhibiting UCP2 Promotes Physiologic Retinal Vascular Development in a Model of Retinopathy of Prematurity

  2019cites this paper
• Experimental Evidence Behind Clinical Trial Outcomes in Retinopathy of Prematurity.

  2019cites this paper
• A Dosing Study of Bevacizumab for ROP: Late Recurrences and Additional Treatments

  2019cites this paper
• Three-dimensional pattern of extraretinal neovascular development in retinopathy of prematurity

  2019cites this paper
• Automatic analysis of the retinal avascular area in the rat oxygen-induced retinopathy model

  2018cites this paper
• Pharmacotherapy and ROP: Going Back to the Basics

  2018cites this paper
• Gene therapy knockdown of VEGFR2 in retinal endothelial cells to treat retinopathy

  2018cites this paper
• A Dosing Study of Bevacizumab for Retinopathy of Prematurity: Late Recurrences and Additional Treatments.

  2018cites this paper
• Role of TLR4‐MAP4K4 signaling pathway in models of oxygen‐induced retinopathy

  2018cites this paper
• Efficacy of intravitreal aflibercept monotherapy in retinopathy of prematurity evaluated by periodic fluorescence angiography and optical coherence tomography

  2018cites this paper
• Targeted Knockdown of Overexpressed VEGFA or VEGF164 in Müller cells maintains retinal function by triggering different signaling mechanisms

  2018cites this paper
• Experimental Animal Models for Retinal and Choroidal Diseases

  2017cites this paper
• Pathophysiology of ROP

  2017cites this paper
• Clinical Management of Recurrent Retinopathy of Prematurity after Intravitreal Bevacizumab Monotherapy.

  2016cites this paper
• Anti-VEGF therapy in the management of retinopathy of prematurity: what we learn from representative animal models of oxygen-induced retinopathy

  2016cites this paper
• PARAFOVEAL CAPILLARY DENSITY AFTER PLAQUE RADIOTHERAPY FOR CHOROIDAL MELANOMA: Analysis of Eyes Without Radiation Maculopathy

  2016cites this paper
• Pathophysiology and mechanisms of severe retinopathy of prematurity.

  2015cites this paper
• Inner retinal oxygen metabolism in the 50/10 oxygen-induced retinopathy model

  2015cites this paper
• Vascular endothelial growth factor antagonist therapy for retinopathy of prematurity.

  2014influential citation